Aladar A. Szalay

Affiliations: 
1962-1988 Biological Sciences Cornell University, Ithaca, NY, United States 
 1973-1977 Biology California Institute of Technology, Pasadena, CA 
 1988-1995 University of Alberta, Edmonton, Alberta, Canada 
 1993-2003 Biochemistry Loma Linda University, Loma Linda, United States 
 2003- Biochemistry Julius-Maximilans-Universität Würzburg, Würzburg, Bayern, Germany 
 2009- Radiation Oncology University of California, San Diego, La Jolla, CA 
Area:
Molecular Biology, Neuroscience Biology, Pharmacology
Website:
https://www.biozentrum.uni-wuerzburg.de/biochem/research-groups/szalay-group-molecular-oncology/members/szalay-aladar-prof-dr/
Google:
"Aladár A. Szalay"
Bio:

http://excelerate-conference.com/speaker/dr-aladar-a-szalay-phd/
https://www.worldcat.org/oclc/74439244
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC343774/

Mean distance: 53433
 

Parents

Sign in to add mentor
Robert L. Sinsheimer post-doc 1973-1975 Caltech (Chemistry Tree)

Children

Sign in to add trainee
Brian G. Ayre grad student 1989-1995 University of Alberta (Chemistry Tree)
Zhong Deng grad student 2000 Loma Linda University
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Haddad D, Socci N, Chen CH, et al. (2016) Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy. Molecular Therapy Oncolytics. 3: 16008
Pugalenthi A, Mojica K, Ady JW, et al. (2015) Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma. Cancer Gene Therapy
Tsoneva D, Stritzker J, Bedenk K, et al. (2015) Drug-Encoded Biomarkers for Monitoring Biological Therapies. Plos One. 10: e0137573
Adelfinger M, Bessler S, Frentzen A, et al. (2015) Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy. Viruses. 7: 4075-92
Kirscher L, Deán-Ben XL, Scadeng M, et al. (2015) Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent. Theranostics. 5: 1045-57
Kober C, Rohn S, Weibel S, et al. (2015) Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps. Journal of Translational Medicine. 13: 216
Ady JW, Johnsen C, Mojica K, et al. (2015) Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma. Surgery
Eveno C, Mojica K, Ady JW, et al. (2015) Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Surgery. 157: 331-7
Pencavel TD, Wilkinson MJ, Mansfield DC, et al. (2015) Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma. International Journal of Cancer. Journal International Du Cancer. 136: 965-76
Cecil A, Gentschev I, Adelfinger M, et al. (2014) Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models. Bioengineered. 5: 319-25
See more...